Visirna Therapeutics Hk Limited
Clinical trials sponsored by Visirna Therapeutics Hk Limited, explained in plain language.
-
New shot slashes fat levels in rare genetic disease
Disease control CompletedThis study tested an injection called Plozasiran in 37 Chinese adults with familial chylomicronemia syndrome (FCS), a rare genetic condition causing extremely high blood fat levels that can lead to severe pancreatitis. The main goal was to see if the drug safely lowers fasting tr…
Phase: PHASE3 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated May 17, 2026 11:54 UTC
-
New cholesterol drug VSA003 passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body processes it. Participants had slightly high cholesterol or triglycerides. The goal was not to treat disease but to gather safety and drug-level data before mo…
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC